Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical Practice

Study Identifier
HUM 03-1
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Rheumatoid Arthritis
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    Observation of safety, tolerability and effectiveness of adalimumab (Humira) therapy in a large patient collective under everyday clinical conditions over a 5-year period.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 35034
    Aachen, Germany, 52062
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 35033
    Aachen, Germany, 52064
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 53919
    Achern, Germany, 77855
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 53883
    Aichhalden, Germany, 78733
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 35041
    Altenburg, Germany, 04600
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 35050
    Amberg, Germany, 92224
    Status
    Not applicable
    Showing {first} - {last} of {total} Results